3 Undervalued Biotechnology Stocks for Tuesday, October 08
Discover the top 3 undervalued Biotechnology stocks for Tuesday, October 08 based on AAII’s Stock Grades.Jenna Brashear
A+ Stock Grade Summary:
| VALUE: |
|
|
| GROWTH: |
|
|
| MOMENTUM: |
|
|
| EPS REVISIONS: |
|
|
| QUALITY: |
|
|
Jenna Brashear
Jack Gilleland
Jenna Brashear
Jack Gilleland
| Share Statistics | AQB | Industry Median |
Percentile (All Stocks) |
|
| Market Cap (Mil) | $6.7 | $286.3 | 4% |
|
| Shares Out (Mil) | 5.1 | 54.2 | 14% |
|
| Institutional Ownership | 94.9% | 92.8% | 66% |
|
| Float (Mil) | 5.1 | 39.7 | 12% |
|
| Beta | 1.40 | 0.94 | 80% |
|
| Avg Daily Volume (000s) | 1,754 | 534 | 80% |
|
| Price Change (52-week) |
78.4% | 58.7% | 87% |
|
| Growth | AQB | Industry Median |
Percentile (All Stocks) |
|
| Sales (5yr) | na | 13.6% | na |
|
| Net Income (5yr) | (2.4%) | (10.1%) | 37% |
|
| EPS (5yr) | 12.0% | 16.0% | 50 |
|
| Dividends (5yr) | na | 0.0% | na |
|
| Cash Flow (5yr) | (73.3%) | (15.6%) | 2% |
|
| Estimates | Qtrly | Current Fiscal Year |
Next Fiscal Year |
|
| # of Estimates | na | na | na | |
| Current EPS | na | na | na | |
| Month Ago EPS | na | na | na | |
| # Rev Up | na | na | na | |
| # Rev Down | na | na | na | |
| Three Months Ago EPS | na | na | na | |
| Year/Year Chg | na | na | na | |
| Financials | AQB | Industry Median |
Percentile (All Stocks) |
|
| Sales (TTM) (Mil) | na | $37 | na |
|
| Net Income (TTM) (Mil) | ($18) | ($43) | 24% |
|
| EPS (TTM) | ($4.201) | ($1.400) | 8% |
|
| Operating Cash Flow (TTM) (Mil) | ($7) | ($31) | 22% |
|
| Net Cash Flow (TTM) (Mil) | na | $2 | na |
|
| Long-Term Debt (Q1) (Mil) | $0 | $4 | 0% |
|
| Enterprise Value (Q1) (Mil) | $6 | $160 | 6% |
|
| Valuation | AQB | Industry Median |
Percentile (All Stocks) |
|
| P/B | 2.38 | 2.77 | 56% |
|
| P/E | na | 19.1 | na |
|
| Dividend Yield | na | 0.0% | na |
|
| PEG (5yr hist) | na | 1.0 | na |
|
| Ratios | AQB | Industry Median |
Percentile (All Stocks) |
|
| Gross Margin | na | 64.2% | na |
|
| Net Margin | na | (75.9%) | na |
|
| ROA | (95.7%) | (47.3%) | 6% |
|
| ROE | (223.5%) | (55.0%) | 4% |
|
| Liabilities to Assets | 76.0% | 29.6% | 71% |
|
| F-Score | 2 | 2 | 7% |
|
AquaBounty Technologies, Inc. did not pass any screens on 8/20/2026.
Price and market data provided by QuoteMedia and delayed a minimum of 15 minutes unless otherwise indicated. Fundamental data provided by AAII's Stock Investor Pro and S&P Global Market Intelligence and are updated through the previous trading day.
Ⓒ 2026 American Association of Individual Investors